Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
4
×
life sciences
national blog main
alirocumab
amgen
boston blog main
clinical trials
evolocumab
inclisiran
new york blog main
new york top stories
regeneron pharmaceuticals
alnylam pharmaceuticals
boston top stories
cholesterol
detroit blog main
detroit top stories
fda
heart attack
medicines co.
national top stories
new york
pcsk9
pcsk9 inhibitors
rna interference
sanofi
statins
stroke
bempedoic acid
boulder/denver blog main
boulder/denver top stories
cardiac
cardiovascular
cause of death
cedar-sinai
circulation
clinical studies
corticosteroids
david maron
deals
What
cholesterol
4
×
drug
4
×
lowering
medicines
new
fda
medco
wave
acquire
agreed
alnylam
approved
based
billion
brings
cash
combo
company
compound
data
deal
drugs
esperion
esperion’s
evidence
expensive
faces
financial
foe
healthcare
heart
hint
inhibitors
known
lasting
levels
long
looms
nod
novartis
Language
unset
Current search:
cholesterol
×
biotech
×
drug
×
@xconomy.com
4 years ago
Esperion’s Combo Pill for Lowering Cholesterol Levels Wins FDA Nod
@xconomy.com
4 years ago
Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B
@xconomy.com
4 years ago
New PCSK9 Cholesterol Drug Faces Tough Foe. (Hint: Not Cholesterol.)
@xconomy.com
5 years ago
MedCo Touts New Data for Long-Lasting Heart Drug as Reckoning Looms